Cost analysis of hemophilia treatment in a Brazilian public blood center
Abstract Background hemophilia is a rare coagulopathy, treated by replacing the missing blood clotting factor. Objective to assess the direct costs of hemophilia treatment from the perspective of the Unified Health System, highlighting the impact costs of new therapeutic modalities. Method partia...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto de Estudos em Saúde Coletiva da Universidade Federal do Rio de Janeiro
2020-12-01
|
| Series: | Cadernos de Saúde Coletiva |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1414-462X2020000400556&tlng=en |